Nissay Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.31M | Buy |
19,199
+268
| +1% | +$66.8K | 0.02% | 343 |
|
|
2025
Q4 | $4.56M | Buy |
18,931
+146
| +0.8% | +$37.3K | 0.02% | 334 |
|
|
2025
Q3 | $5.14M | Buy |
18,785
+127
| +0.7% | +$34.7K | 0.03% | 314 |
|
|
2025
Q2 | $4.81M | Buy |
18,658
+106
| +0.6% | +$25.3K | 0.03% | 328 |
|
|
2025
Q1 | $4.15M | Buy |
18,552
+225
| +1% | +$52.5K | 0.03% | 346 |
|
|
2024
Q4 | $4.27M | Sell |
18,327
-467
| -2% | -$112K | 0.03% | 342 |
|
|
2024
Q3 | $4.59M | Buy |
18,794
+480
| +3% | +$107K | 0.03% | 339 |
|
|
2024
Q2 | $3.51M | Sell |
18,314
-663
| -3% | -$135K | 0.02% | 373 |
|
|
2024
Q1 | $3.76M | Buy |
18,977
+74
| +0.4% | +$13.6K | 0.03% | 356 |
|
|
2023
Q4 | $3.25M | Buy |
18,903
+732
| +4% | +$112K | 0.03% | 353 |
|
|
2023
Q3 | $2.69M | Buy |
18,171
+523
| +3% | +$94.6K | 0.02% | 368 |
|
|
2023
Q2 | $3.86M | Buy |
17,648
+239
| +1% | +$53.3K | 0.03% | 299 |
|
|
2023
Q1 | $3.81M | Sell |
17,409
-551
| -3% | -$120K | 0.03% | 288 |
|
|
2022
Q4 | $3.74M | Sell |
17,960
-111
| -0.6% | -$24.4K | 0.04% | 290 |
|
|
2022
Q3 | $3.94M | Buy |
18,071
+642
| +4% | +$146K | 0.04% | 265 |
|
|
2022
Q2 | $3.65M | Sell |
17,429
-399
| -2% | -$84.9K | 0.04% | 274 |
|
|
2022
Q1 | $4.32M | Sell |
17,828
-5,443
| -23% | -$1.32M | 0.04% | 282 |
|
|
2021
Q4 | $6.06M | Sell |
23,271
-175
| -0.7% | -$45.4K | 0.05% | 227 |
|
|
2021
Q3 | $6.18M | Buy |
23,446
+520
| +2% | +$142K | 0.05% | 203 |
|
|
2021
Q2 | $5.65M | Sell |
22,926
-1,291
| -5% | -$271K | 0.05% | 217 |
|
|
2021
Q1 | $4.7M | Buy |
24,217
+724
| +3% | +$145K | 0.05% | 234 |
|
|
2020
Q4 | $4.99M | Buy |
23,493
+7,889
| +51% | +$1.57M | 0.08% | 199 |
|
|
2020
Q3 | $2.67M | Sell |
15,604
-4,627
| -23% | -$854K | 0.05% | 304 |
|
|
2020
Q2 | $3.88M | Sell |
20,231
-740
| -4% | -$121K | 0.08% | 228 |
|
|
2020
Q1 | $3.09M | Buy |
20,971
+352
| +2% | +$56.1K | 0.08% | 236 |
|
|
2019
Q4 | $3.19M | Sell |
20,619
-1,884
| -8% | -$272K | 0.07% | 293 |
|
|
2019
Q3 | $3.04M | Sell |
22,503
-813
| -3% | -$107K | 0.07% | 292 |
|
|
2019
Q2 | $2.85M | Sell |
23,316
-11,908
| -34% | -$1.32M | 0.07% | 304 |
|
|
2019
Q1 | $3.66M | Sell |
35,224
-1,384
| -4% | -$143K | 0.1% | 244 |
|
|
2018
Q4 | $4.17M | Buy |
36,608
+2,197
| +6% | +$235K | 0.13% | 201 |
|
|
2018
Q3 | $3.97M | Sell |
34,411
-3,108
| -8% | -$340K | 0.11% | 231 |
|
|
2018
Q2 | $3.89M | Buy |
37,519
+7,725
| +26% | +$782K | 0.11% | 221 |
|
|
2018
Q1 | $2.93M | Buy |
29,794
+171
| +0.6% | +$16.2K | 0.09% | 271 |
|
|
2017
Q4 | $2.51M | Buy |
+29,623
| New | +$2.45M | 0.08% | 312 |
|
Other funds holding RMD
VCM
VPM
DAM
Nissay Asset Management's RMD Position: Q1 2026 in Review
Nissay Asset Management increased its ResMed (RMD) stake by 1.4% in Q1 2026, buying an estimated $66.8K and bringing the position to 19,199 shares worth $4.31M. The position accounts for 0.02% of the portfolio, ranked #343.
Nissay Asset Management first reported a position in RMD in Q4 2017 and has held it in 34 quarters since. The position peaked at $6.18M in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Nissay Asset Management held 19,199 shares of ResMed worth $4.31M as of Q1 2026.
- Nissay Asset Management bought 268 ResMed shares in Q1 2026, an estimated $66.8K.
- ResMed made up 0.02% of Nissay Asset Management's portfolio in Q1 2026, its #343 holding.
- Nissay Asset Management first reported a position in ResMed in Q4 2017 and has held it in 34 quarters since.
- Nissay Asset Management's ResMed position peaked at $6.18M in Q3 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Nissay Asset Management's 13F filing for Q1 2026, filed 15 May 2026.